Asia Pacific Omega 3 Market Research Analysis 2020-2025:
Asia Pacific Omega 3 Market was calculated at USD xx billion in 2019 and is foreseen to develop up to USD xx billion by the end of 2025 with a considerable growth rate over the conjecture period (2020-2025).
Omega-3s are a family of fats important for health, which are divided into alpha-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid. The human body cannot prepare ALA (alpha-linolenic acid), so it must be consumed. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain fats that can be made from ALA in our bodies.
- In October 2019, KD Pharma introduced Kardio3, which is a blend of omega-3s, vitamin K2, and phytosterols. It helps maintain healthy lipids and supports heart and bone health.
- In September 2019, Polaris introduced Omegavie DHA 700 algae Sensory QualitySilver, which is supposed to aid the company in the omega-3 algae sector. The product is mainly concentrated in DHA and also contains excellent organoleptic properties.
- In September 2019, Epax is planning to make a funding of $ 35 million in the next two years for implementing new developments in omega-3 sector. This investment will allow Epax to have better capacity in the omega-3 sector at its main production site in Norway.
- In May 2019, KD Pharma acquired a manufacturing site in the United Kingdom to increase its omega-3 supplement manufacturing capacity.
- Market Drivers and Restraints:
Increased investments by various companies to improve manufacturing capacity, strengthen R&D activities for the production of new products, increase the demand for the production of infant formulas for development and better infant growth, and increased adoption of Omega-3 fatty acids in the animal feed industry to provide improved performance are important factors that are expected to contribute to the growth of the Asia Pacific omega 3 market during the outlook period. The importance of omega-3s in infant nutrition in the Asia-Pacific region is unprecedented; and as a result, there is a high demand for omega-3 products. This growing demand for infant nutrition is driving the omega-3 market in the Asia-Pacific, underpinned by the health attributes it offers for prenatal and postnatal care. China and India are the world’s largest consumers of infant formula, due to high birth rates in the countries. China accounted for around a third of the infant formula market in 2015, while infant formula is also the largest food segment, where the average annual delivery exceeds 25 million children.
However, excessive consumption of omega-3 leads to gastrointestinal diseases such as diarrhea, fish breath, upset stomach and nausea, which are a major factor holding back the growth of the Asia Pacific omega 3 market. The cost of fish and other marine oils used to extract omega-3s is high and highly unstable. This factor poses a challenge to the growth of the local market. Fluctuating raw material prices negatively affect the omega-3 industry. The sudden increase in the prices of these raw materials is due to the increase in the cost of aquaculture. Food is the main input for aquaculture, and food prices are continually changing due to the high cost of maintaining aquaculture. The cost of imported or purchased fish also increases considerably. Increasing manpower, energy and energy costs and restrictions on deep sea fishing further slow down the growth of the industry. Therefore, the increase in the prices of raw materials creates a challenge for the growth of the APAC omega-3 market.
The market segmentation for Asia Pacific Omega 3 has been divided into type, source, and application.
Depending on the type, the market is divided into eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and alpha-linolenic acid (ALA). The combination of DHA and EPA helps reduce bad cholesterol and coronary heart disease such as stroke and blood pressure, which, in turn, should boost the growth of these segments. In this sense, the higher incidence of heart disease in individuals due to an unhealthy lifestyle is likely to fuel the demand for omega 3. Due to increased aquaculture activities, mainly in Asia Pacific. The abundant availability of agricultural land and favorable climatic conditions should stimulate the demand for foods containing omega 3.
In terms of application, the Asia Pacific omega 3 market is divided into functional foods and supplements, pharmaceuticals, instant formulas, pet food, and more. The functional foods and supplements segment dominated the industry in 2019 due to the various health benefits of omega-3 fatty acids, rising R&D initiatives, and rising healthcare costs. The increasing use of dietary supplements to maintain fitness and nutrient adequacy in adults should increase omega 3 consumption in dietary supplements. Supplements and functional foods are consumed primarily to ensure the supply of important nutritional components for the human body. The increase in the number of cardiovascular diseases due to the slow and inactive lifestyle, especially in the age group of 30 to 40 years, and fluctuating diets are the factors that should drive the importance of omega 3 nutraceutical products in the market in the coming years.
Depending on the source, the omega-3 industry falls into two categories, namely marine sources and plant sources. In terms of revenue, the marine source of omega 3 fatty acids accounted for an 82.5% share in 2019 and should experience significant growth during the forecast period. Demand for marine products is fueled by growing consumer interest in omega 3 fatty acids extracted from fish and krill oils. Increased consumption of omega 3s in the form of fortified food products, such as fish ham and fish sausages, should stimulate the segment in the coming years. Furthermore, increasing awareness of consuming high triglycerides is expected to drive demand for omega-3 fortified foods.
Impact of COVID-19 on Asia Pacific Omega 3 Market
The coronavirus pandemic has had a significant impact on food sector worldwide, including all stages of the supply and value chain of various industries. Food and beverages are among the industries that are currently experiencing adverse effects of this pandemic. Production, distribution and inventory levels across the spectrum of the food and beverage industry are expected to be affected. The affected workforce on farms, food and beverage production and processing plants, and the distribution network are analyzed to risk promoting the COVID-19, which can occur during various coordination activities. There is also a potential risk that the virus will spread through outbound products, leading to food security problems, when trade occurs between geographic areas and different stages of the supply chain, resulting in a shortage of manpower working.
The Asia Pacific Omega 3 market has been divided by geography into China, Taiwan, South Korea, India, Japan, Australia, and New Zealand, and the rest of the Asia-Pacific. Asia-Pacific is supposed to experience considerable growth over the forecast period due to growing demand for products in countries mentioned above. The increased consumption of fish oil in the daily diet, as well as a greater health awareness increases the demand for omega 3 in this region. Furthermore, the growing cultivation of krill in the South China Sea and the Indian Ocean should boost the growth of the regional market in the coming years.
Cargill Inc. had the largest share of the Asia Pacific Omega 3 Market in terms of sales and revenue in 2019.
- Pharma Marine AS
- Luhua Biomarine (Shandong) Co., Ltd.
- GC Rieber Oils
- Omega Protein Corporation
- OLVEA Fish Oils
- Royal DSM
- Croda International Plc
- FMC Corporation
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2.2 Dietary Supplements
5.2.3 Functional Foods and Beverages
5.2.5 Infant Formula
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3.4 Y-o-Y Growth Analysis, By Source
5.3.5 Market Attractiveness Analysis, By Source
5.3.6 Market Share Analysis, By Source
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
22.214.171.124 By Application
126.96.36.199 By Source
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Type
220.127.116.11 By Application
18.104.22.168 By Source
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Type
188.8.131.52 By Application
184.108.40.206 By Source
6.2.6 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders’ Analysis
8.1 Aker BioMarine
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Rieber Oils AS and Lonza
8.4 BASF SE
8.6 Omega Proteine Company
8.7 Luhua Biomarine (Shandong) Co., Ltd
8.8 Croda International Plc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures